View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
January 17, 2018

FDA clears Medtronic’s Riptide device for acute ischemic stroke

Medtronic's Neurovascular business division has obtained clearance from the US Food and Drug Administration (FDA) for its Riptide Aspiration System to treat acute ischemic stroke.

Medtronic’s Neurovascular business division has obtained clearance from the US Food and Drug Administration (FDA) for its Riptide Aspiration System to treat acute ischemic stroke.

Free Report
img

Find the right pricing strategy for your medical device

How do your competitors set prices in different markets? Will reducing your prices win market share from your main competitors? Do you need to position products differently for different markets? To find out, use our Global Brand Pricing tool to achieve optimal pricing for your devices. Detect price changes, understand competitor market positioning, and plan new product launches, by accessing this tool today. It features:
  • A proprietary algorithm that leverages numerous pricing sources, with an emphasis on real-world data
  • Estimates of the likely spread of selling prices per brand and manufacturer, as well as 3-year forecasts for prices
  • Medical device pricing data that can be tracked by market, company, and brand
  • Additional categories that can be built on a custom basis
Use our tool to access competitor pricing strategies across multiple geographies, and various dynamic case studies from the likes of Germany and China, to benchmark yourself against your competitors and future proof your pricing strategies.
by GlobalData
Enter your details here to receive your free Report.

The Riptide Aspiration System includes the Arc Catheter, Riptide Aspiration Pump, Riptide Aspiration Tubing, and Riptide Collection Canister with intermediate tubing.

The system is intended to restore blood flow in blocked arteries of ischemic stroke patients by retrieving the clot through the Arc Catheter, which is inserted via an incision in the leg and up to the specific artery.

Riptide is used for the revascularisation of patients affected by acute ischemic stroke secondary to intracranial large vessel occlusive disease within eight hours of onset of the symptoms.

“The system can be used to treat patients who are not eligible or fail therapy with intravenous tissue plasminogen activator (IV tPA).”

The system can be used to treat patients who are not eligible or fail therapy with intravenous tissue plasminogen activator (IV tPA).

It expands Medtronic’s portfolio of revascularisation devices for acute ischemic stroke, including Solitaire with Parametric technology to restore blood flow and MindFrame Capture LP device to treat distal zone occlusions.

Medtronic Restorative Therapies Group Neurovascular business vice-president and general manager Stacey Pugh said: “Medtronic is committed to developing services and solutions that address healthcare needs by improving clinical and economic outcomes.

“We believe that the Riptide Aspiration System and Solitaire Revascularisation Device provide our customers with a comprehensive suite of products to choose from.”

Related Companies

Free Report
img

Find the right pricing strategy for your medical device

How do your competitors set prices in different markets? Will reducing your prices win market share from your main competitors? Do you need to position products differently for different markets? To find out, use our Global Brand Pricing tool to achieve optimal pricing for your devices. Detect price changes, understand competitor market positioning, and plan new product launches, by accessing this tool today. It features:
  • A proprietary algorithm that leverages numerous pricing sources, with an emphasis on real-world data
  • Estimates of the likely spread of selling prices per brand and manufacturer, as well as 3-year forecasts for prices
  • Medical device pricing data that can be tracked by market, company, and brand
  • Additional categories that can be built on a custom basis
Use our tool to access competitor pricing strategies across multiple geographies, and various dynamic case studies from the likes of Germany and China, to benchmark yourself against your competitors and future proof your pricing strategies.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network